Each 0.8 ml single dose pre-filled pen contains 40 mg of adalimumab.
Adalimumab is a recombinant human monoclonal antibody produced in Chinese hamster ovary cells.
ABRILADA is a biosimilar medicine to HUMIRA. The evidence for comparability supports the use of ABRILADA for the listed indications. Abrilada is not interchangeable or automatically substitutable with Adalimumab.
Excipients/Inactive Ingredients: L Histidine, L Histidine hydrochloride monohydrate, Sucrose, Edetate Disodium Dihydrate, L Methionine, Polysorbate 80, Water for injections.